Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/27/2026, 10:25:37 AM
    Content snapshot
    {
      "session_id": "sess-hyp-1b87d283fc0c",
      "round_number": 1,
      "agent_persona": "persona-theorist",
      "agent_backend": "llm",
      "action": "propose",
      "content": "\n\n# Critical Evaluation: TREM2 Microglial Activation Rescues Amyloid Clearance in Alzheimer's Disease\n\n---\n\n## Mechanistic Rationale\n\nThe hypothesis rests on a coherent, genetically informed mechanism connecting TREM2 function to microglial-mediated amyloid homeostasis. TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) is a surface receptor enriched in microglia and macrophages that signals through a structured cascade: **SYK kinase → PLCγ2 → CARD9 → NF-κB/calcineurin-NFAT signaling**. This pathway modulates microglial survival, proliferation, chemotaxis toward plaques, and phagocytic capacity.\n\n**R47H Variant Implicates Loss-of-Function**: The ~3-fold increased AD risk associated with R47H (affecting TREM2 ligand-binding Ig-like domain) is consistent with haploinsufficiency reducing microglial amyloid surveillance. R47H impairs binding to anionic lipid surfaces (e.g., ApoE-coated amyloid) and reduces TREM2 surface expression via misfolding-promoted degradation. This provides genetic \"proof-of-concept\" that insufficient TREM2 signaling predisposes to amyloid accumulation.\n\n**Mechanistic Logic Chain**:\n1. Amyloid deposition triggers microglial recruitment via fractalkine (CX3CL1-CX3CR1) and complement pathways\n2. TREM2 engagement on plaque-associated microglia amplifies phagocytic signaling\n3. Agonistic antibodies bypass R47H partial loss-of-function to restore SYK/PLCγ2 activation\n4. Enhanced phagocytosis and lysosomal degradation reduce plaque burden\n5. Plaque compaction (denser, more discrete morphology) limits neuritic dystrophy\n\n**Plausible Alternative Interpretations**: The primary effect may not be increased amyloid *clearance* but rather **improved amyloid *containment***—microglia surround plaques more effectively, reducing outward plaque growth and limiting toxic soluble oligomer diffusion.",
      "tokens_used": "459",
      "persona_id": "persona-theorist"
    }